Sebia and Janssen join forces to develop IVD test for myeloma

Sebia, the French specialty diagnostics company, has announced that it is collaborating with Janssen Biotec Inc. to develop an in vitro diagnostic (IVD) test that mitigates the potential interference darartumumab (Darzalex┬«) can cause when visualising monoclonal proteins by immunofixation electrophoresis. Daratumumab, an anti-CD38 human monoclonal antibody currently being developed by Janssen as a treatment for…

Details